Carregant...
Treatment of hepatitis C virus genotype 4 in the DAA era
The recently approved interferon-free DAA (direct antiviral agents) regimens have shown not only to be effective in terms of sustained virological response (SVR) rates (> 90%) but also well tolerated in most hepatitis C virus (HCV) infected patients. Nevertheless HCV genotypes are different and o...
Guardat en:
| Publicat a: | Virol J |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6251143/ https://ncbi.nlm.nih.gov/pubmed/30466446 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-018-1094-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|